Skip to main content
OpenTrials

Clinical trial condition

HER2/Neu Positive

Explore clinical trials studying HER2/Neu Positive. Study availability and eligibility vary by location and protocol.

14 public trials 1 recruiting study
Refine in advanced search Browse all conditions

HER2/Neu Positive trial results

Recruiting

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

NCT03418961

Conditions
Brain Diseases, Brain Neoplasms, Breast Diseases, +22 more
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
  • Alaska Women's Cancer Care Anchorage, Alaska, United States
View all 590 locations
View Trial Details
Completed

Paclitaxel & Cyclophosphamide With or Without Trastuzumab Before Surgery in Treating Previously Untreated Breast Cancer

NCT01750073

Conditions
Breast Diseases, Breast Neoplasms, Estrogen Receptor Negative, +20 more
Locations
  • Nebraska Medicine-Bellevue Bellevue, Nebraska, United States
  • CHI Health Saint Francis Grand Island, Nebraska, United States
  • Nebraska Medicine-Village Pointe Cancer Center Omaha, Nebraska, United States
  • University of Nebraska Medical Center Omaha, Nebraska, United States
View Trial Details
Completed

Paclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer

NCT00785291

Conditions
Breast Diseases, Breast Neoplasms, Estrogen Receptor Negative, +12 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Sparks Regional Medical Center Fort Smith, Arkansas, United States
  • Mercy Hospital Fort Smith Fort Smith, Arkansas, United States
  • NEA Baptist Memorial Hospital Jonesboro, Arkansas, United States
View all 704 locations
View Trial Details
Completed

Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer

NCT01275677

Conditions
Breast Diseases, Breast Neoplasms, HER2/Neu Positive, +12 more
Locations
  • Northeast Alabama Regional Medical Center Anniston, Alabama, United States
  • Providence Hospital Mobile, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
View all 1283 locations
View Trial Details
Completed

Everolimus, Letrozole and Trastuzumab in HR- and HER2/Neu-positive Patients

NCT02152943

Conditions
Advanced Malignant Solid Neoplasm, Breast Diseases, Breast Neoplasms, +16 more
Locations
  • M D Anderson Cancer Center Houston, Texas, United States
  • MD Anderson in Katy Houston, Texas, United States
  • MD Anderson League City Nassau Bay, Texas, United States
  • MD Anderson in Sugar Land Sugar Land, Texas, United States
View Trial Details
Completed

Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Can Be Removed by Surgery

NCT00513292

Conditions
Breast Diseases, Breast Neoplasms, HER2/Neu Positive, +8 more
Locations
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Eden Hospital Medical Center Castro Valley, California, United States
  • Marin Cancer Care Inc Greenbrae, California, United States
  • Saint Rose Hospital Hayward, California, United States
View all 115 locations
View Trial Details

Related conditions